Royal London Asset Management LTD Vertex Pharmaceuticals Inc Transaction History
Royal London Asset Management LTD
- $40.9 Billion
- Q1 2025
A detailed history of Royal London Asset Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Royal London Asset Management LTD holds 335,642 shares of VRTX stock, worth $146 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
335,642
Previous 363,278
7.61%
Holding current value
$146 Million
Previous $146 Million
11.23%
% of portfolio
0.4%
Previous 0.37%
Shares
31 transactions
Others Institutions Holding VRTX
# of Institutions
1,830Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.29 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.34 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.14 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $112B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...